A novel peptide interferes with Mycobacterium tuberculosis virulence and survival
Tuberculosis (TB) is a huge global burden, with new and resistant strains emerging at an alarming rate, necessitating an urgent need for a new class of drug candidates.Here, we report that SL3, a novel 33-amino acid peptide, sharpener guide causes debilitating effects on mycobacterial morphology.Treatment with SL3 drastically inhibits the growth of